UnknownNot Applicable

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

United States2,000 participantsStarted 2005-10

Plain-language summary

RATIONALE: Finding specific proteins in the blood may help doctors tell whether a patient has ovarian cancer. PURPOSE: This clinical trial is studying how well proteomic profiling works in diagnosing ovarian cancer in patients who are undergoing surgery for an abnormal pelvic mass.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Abnormal pelvic mass by physical examination or imaging test * Undiagnosed * Planning to undergo surgical evaluation within the next 3 weeks PATIENT CHARACTERISTICS: Performance status * Not specified Life expectancy * Not specified Hematopoietic * Not specified Hepatic * Not specified Renal * Not specified Other * Negative pregnancy test PRIOR CONCURRENT THERAPY: Surgery * See Disease Characteristics

What they're measuring

Proteomic proflie (i.e. discrimination of tumor from nontumor in pelvic mass)

Trial details

NCT IDNCT00238342

SponsorGynecologic Oncology Group

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2007-10

View on ClinicalTrials.gov More Fallopian Tube Cancer trials